The US FDA has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted to the agency from 2020 to 2024.

Sitamraju Sree Ramakrishna, manager projects, at GlaxoSmithKline Consumer Healthcare’s (GSKCH) Rajahmundry factory, raised a ...

Still let’s pause here to appreciate the legal theory being advanced by Cloud Innovation: that sharing a link to an article ...